Adenocarcinomas of the papilla of Vater are highly aggressive malignancies with an unchanged poor prognosis. Although postoperative mortality has declined and resection rates have improved considerably, the reported 5-year survival rates after complete tumor resection (R0) still range between 45% and 65%[ 1 x [1] Beger, H.G., Thorab, F.C., Liu, Z., Harada, N., and Rau, B.M. Pathogenesis and treatment of neoplastic diseases of the papilla of Vater: Kausch-Whipple procedure with lymph node dissection in cancer of the papilla of Vater. J Hepatobiliary Pancreat Surg. 2004; 11: 232–238 Crossref | PubMed | Scopus (29) | Google Scholar See all References ] [1] . Early metastatic relapse after the complete resection of an apparently localized primary tumor indicates an occult tumor cell dissemination or micrometastatic disease, which cannot be detected by current staging procedures. Therefore, more sensitive immunohistochemical and nucleic acid-based assays have been developed that are based on the detection of epithelial cell or tumor-associated markers and are able to detect disseminated tumor cells in lymph nodes classified as ‘tumor-free’ by conventional histopathologic examination [ 2 x [2] Bonavina, L., Ferrero, S., Midolo, V., Buffa, R., Cesana, B., and Peracchia, A. Lymph node micrometastases in patients with adenocarcinoma of the esophagogastric junction. J Gastrointest Surg. 1999; 3: 468–476 Crossref | PubMed | Scopus (38) | Google Scholar See all References , 3 x [3] Calaluce, R., Miedema, B.W., and Yesus, Y.W. Micrometastasis in colorectal carcinoma: a review. J Surg Oncol. 1998; 67: 194–202 Crossref | PubMed | Scopus (92) | Google Scholar See all References , 4 x [4] Greenson, J.K., Isenhart, C.E., Rice, R., Mojzisik, C., Houchens, D., and Martin, E.W. Jr. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer. 1994; 73: 563–569 Crossref | PubMed | Scopus (402) | Google Scholar See all References , 5 x [5] Hosch, S., Kraus, J., Scheunemann, P., Izbicki, J.R., Schneider, C., and Schumacher, U. Malignant potential and cytogenetic characteristics of occult disseminated tumor cells in esophageal cancer. Cancer Res. 2000; 60: 6836–6840 PubMed | Google Scholar See all References , 6 x [6] Hosch, S.B., Knoefel, W.T., Metz, S., Stoecklein, N., Niendorf, A., and Broelsch, C.E. Early lymphatic tumor cell dissemination in pancreatic cancer: frequency and prognostic significance. Pancreas. 1997; 15: 154–159 Crossref | PubMed | Scopus (72) | Google Scholar See all References , 7 x [7] Kano, M., Shimada, Y., Kaganoi, J., Sakurai, T., Li, Z., and Sato, F. Detection of lymph node metastasis of oesophageal cancer by RT-nested PCR for SCC antigen gene mRNA. Br J Cancer. 2000; 82: 429–435 Crossref | PubMed | Google Scholar See all References , 8 x [8] Komukai, S., Nishimaki, T., Watanabe, H., Ajioka, Y., Suzuki, T., and Hatakeyama, K. Significance of immunohistochemically demonstrated micrometastases to lymph nodes in esophageal cancer with histologically negative nodes. Surgery. 2000; 127: 40–46 Abstract | Full Text | Full Text PDF | PubMed | Scopus (62) | Google Scholar See all References , 9 x [9] Kubuschok, B., Passlick, B., Izbicki, J.R., Thetter, O., and Pantel, K. Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer. J Clin Oncol. 1999; 17: 19–24 PubMed | Google Scholar See all References , 10 x [10] Liefers, G.J., Cleton-Jansen, A.M., van de Velde, C.J., Hermans, J., van Krieken, J.H., and Cornelisse, C.J. Micrometastases and survival in stage II colorectal cancer. N Engl J Med. 1998; 339: 223–228 Crossref | PubMed | Scopus (530) | Google Scholar See all References , 11 x [11] Lindblom, A. Improved tumor staging in colorectal cancer. N Engl J Med. 1998; 339: 264–265 Crossref | PubMed | Scopus (12) | Google Scholar See all References , 12 x [12] Millis, R.R., Springall, R., Lee, A.H., Ryder, K., Rytina, E.R., and Fentiman, I.S. Occult axillary lymph node metastases are of no prognostic significance in breast cancer. Br J Cancer. 2002; 86: 396–401 Crossref | PubMed | Scopus (84) | Google Scholar See all References , 13 x [13] Nakamura, T., Ide, H., Eguchi, R., Hayashi, K., Ota, M., and Takasaki, K. Clinical implications of lymph node micrometastasis in patients with histologically node-negative (pN0) esophageal carcinoma. J Surg Oncol. 2002; 79: 224–229 Crossref | PubMed | Scopus (32) | Google Scholar See all References , 14 x [14] Passlick, B., Izbicki, J.R., Kubuschok, B., Nathrath, W., Thetter, O., and Pichlmeier, U. Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer. J Clin Oncol. 1994; 12: 1827–1832 PubMed | Google Scholar See all References , 15 x [15] Sidransky, D. Nucleic acid-based methods for the detection of cancer. Science. 1997; 278: 1054–1059 Crossref | PubMed | Scopus (302) | Google Scholar See all References , 16 x [16] Cote, R.J., Peterson, H.F., Chaiwun, B., Gelber, R.D., Goldhirsch, A., and Castiglione-Gertsch, M. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet. 1999; 354: 896–900 Abstract | Full Text | Full Text PDF | PubMed | Scopus (451) | Google Scholar See all References ]. However, although an increasing number of published studies indicate that immunohistochemically detected minimal tumor cell deposits in ‘tumor-free’ lymph nodes appeared to be strong and independent predictors of tumor relapse in several carcinoma entities [ 5 x [5] Hosch, S., Kraus, J., Scheunemann, P., Izbicki, J.R., Schneider, C., and Schumacher, U. Malignant potential and cytogenetic characteristics of...